Adopting the Evolving Management of HR+/HER2-mBC into Practice
Annenberg Center for Health Sciences
- 4
- Episodes
- 2025
- First episode
About Adopting the Evolving Management of HR+/HER2-mBC into Practice
Survival outcomes for patients with HR+/HER2- mBC remain suboptimal, despite first-line treatment strategies with endocrine therapy (ET). Greater understanding of the biology of HR+/HER2- mBC, including the role of biomarkers like ESR1 mutations, and the development of biopsy techniques for early mutation detection, have paved the way for personalized treatment approaches. In this activity, medical oncologists discuss integrating these evidence-based advancements into practice.
- Publisher
- Annenberg Center for Health Sciences
- Category
- health & fitness
- Language
- en
- Explicit
- No
- First episode
- 9 Apr 2025
- Latest episode
- 9 Apr 2025
Latest episodes
4 episodes in the feed.
9 Apr 2025
Therapeutic Approaches for the Treatment of Patients with HR+/HER2- mBC
9 Apr 2025
Navigating Through the Current Treatment of Patients with HR+/HER2- mBC
9 Apr 2025
Molecular and Tumor Profiling
9 Apr 2025
Background and Scope for Management of Patients with HR+/HER2- mBC
Podcast Authority Score: 5 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
- Quality
- 10
- Social presence
- 0
- YouTube
- 0
- Engagement
- 0
Contact Adopting the Evolving Management of HR+/HER2-mBC into Practice
- Guest appearances
- Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Adopting the Evolving Management of HR+/HER2-mBC into Practice?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show
Podcast research with Pod Engine